
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs raised $5 billion in Series C funding to move AI-designed drug candidates toward clinical trials, co-led by Greenoaks and Sequoia Capital, with participation from existing backers.
Isomorphic Labs, the AI drug-discovery platform spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round as it seeks to take its drug candidates to clinical trials. The round was co-led by Greenoaks and Sequoia Capital, with new investor Andreessen Horowitz and other investors also participating. All of the company’s existing backers also invested, including Alphabet’s venture divisions GV and Capital G, Thrive Capital, MGX, Temasek, and the UK Sovereign AI Fund.
What the funding will support
The new funding, which comes on the heels of a $2.1 billion Series B round in May, will be used to continue developing Isomorphic’s drug-design engine and to move into more types of medicine. The company builds an AI drug-design engine that uses a slew of simulation AI models exploring various areas of chemistry to help it design drugs. It has also struck deals with pharma giants Eli Lilly, Novartis, and Johnson & Johnson.
Preclinical progress
Isomorphic’s work builds on DeepMind’s AlphaFold protein-folding AI model. The company said its program has yielded positive preclinical results in oncology and immunology. The lab did not disclose its new valuation, though Bloomberg reported earlier this month that it was looking to raise funding at a $50 billion valuation.
Leadership and AlphaFold recognition
The Series C is Isomorphic’s first fundraise since founder and CEO Demis Hassabis left his position as head of DeepMind to focus on drug discovery, a move that also saw him take a chairman role at DeepMind. Hassabis and then-director of DeepMind John Jumper won the Nobel Prize in chemistry for the lab’s work on AlphaFold, a system that predicts the 3D structure of proteins with nothing more than their genetic sequence.
SiTech.ge reported in October that Isomorphic was in talks to raise funds at a $40 billion valuation, before Bloomberg put the target at $50 billion this month.
Sources: TechCrunch
SiTech — AI-powered web development
We build fast, modern websites and bring AI into real business workflows. Have a project or a question? We'd love to help.